BiotechTube
Home/AbelZeta Pharma/Michael Havert, Ph.D.
MH

Michael Havert, Ph.D.

Senior Vice President, Regulatory Affairs & Quality, US

AbelZeta Pharma

Therapeutic Areas

Hematologic MalignanciesInflammatory & Immunological DiseasesSolid Tumors

AbelZeta Pharma Pipeline

DrugIndicationPhase
Not Specified (Hematologic Malignancies)Hematologic MalignanciesClinical
Not Specified (Inflammatory & Immunological)Inflammatory & Immunological DiseasesClinical
Not Specified (Solid Tumors)Solid TumorsClinical

Leadership Team at AbelZeta Pharma

T(
Tony (Bizuo) Liu
Chairman and CEO
YY
Yihong Yao, Ph.D., BS
Chief Scientific Officer
AC
Andrew Chan, JD, MBA
Chief Legal Officer and Company Secretary
JH
Jiaqi Huang, MD, Ph.D.
Senior Vice President, Translational Medicine
MM
Matt Mandel, MD
Senior Vice President, Clinical
View full AbelZeta Pharma profile